Kidney Stone Management Market - By Type (Calcium Oxalate, Calcium Phosphate, Uric Acid, Struvite, Cysteine), Diagnostics (Abdominal X-ray, CT, Ultrasound, Abdominal MRI, Intravenous Pyelography), Treatment (Ureteroscopy), End-use & Forecast, 2024 – 2032

Kidney Stone Management Market Size

Kidney Stone Management Market size was valued at around USD 2.6 billion in 2023 and is expected to reach around USD 4.1 billion by 2032 at a CAGR of 5.1% during the forecast period. The market is expected to witness robust growth owing to the increasing prevalence and high recurrence rates of kidney stones and the continual introduction of technologically advanced products.
 

Kidney stones have a high recurrence rate, with many patients experiencing multiple episodes in their lifetime, necessitating ongoing management and treatment. For instance, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) in the U.S. reports that approximately 11% of men and 6% of women in the U.S. develops kidney stones at some point in their lives. As the global population ages and lifestyle factors continue to contribute to kidney stone formation, the demand for effective management and treatment solutions will fuel market progression.
 

Kidney stone management refers to the comprehensive set of medical procedures, treatments, and lifestyle adjustments aimed at preventing, diagnosing, and treating kidney stones. Kidney stones are hard minerals and salt deposits that form in the kidneys and can cause severe pain and other complications when they move through the urinary tract.
 

Kidney Stone Management Market Trends

The market is experiencing significant growth driven by advancements in ureteroscopy and other cutting-edge technologies. These innovations are improving the effectiveness and safety of treatments, leading to better patient outcomes and greater adoption of minimally invasive techniques.

• The development of virtual reality (VR) simulators for training urologists in ureteroscopy and other endourological procedures is enhancing proficiency and reducing the learning curve for new technologies.
   
• Additionally, laser technology is widely used to break down kidney stones into smaller fragments that can be easily removed or passed naturally. Recent advancements include more powerful and precise laser systems capable of efficiently treating stones of varying sizes and compositions.
   
• Moreover, advancements in extracorporeal shock wave lithotripsy (ESWL) technology have improved the efficiency and safety of non-invasive stone fragmentation. Modern ESWL devices offer better targeting and energy delivery, reducing the number of treatment sessions required.
   
• Furthermore, innovations in percutaneous nephrolithotomy (PCNL) techniques, such as the use of smaller instruments (mini-PCNL) and improved imaging guidance, have made the procedure less invasive. Enhanced nephroscopes and stone retrieval tools contribute to more effective and safer stone removal. These advancements are expected to attract more patients and healthcare professionals, driving demand in the market.
   

Kidney Stone Management Market Analysis

Based on type, the market is categorized into calcium oxalate, calcium phosphate, uric acid, struvite, and cysteine. The calcium oxalate segment held majority market share with a revenue of USD 1.9 billion in 2023.
 

• Calcium oxalate stones are the most common type of kidney stones, accounting for about 75-80% of all cases. Their prevalence is significantly higher compared to other types of stones, making them the dominant segment.
   
• Moreover, diets rich in oxalate-containing foods (such as spinach, nuts, and chocolate) and high in calcium can increase the risk of calcium oxalate stone formation. Such factors are anticipated to contribute to the segmental growth.
   

Based on diagnostics, the kidney stone management market is categorized into abdominal x-rays, computed tomography, ultrasound, abdominal MRI, intravenous pyelography, and other diagnostics. The computed tomography segment accounted for leading share in 2023 and anticipated to reach USD 1.3 billion by 2032.
 

• CT scans can be performed quickly, often within minutes, making them ideal for emergency settings where rapid diagnosis is critical.
   
• Additionally, CT is a non-invasive diagnostic tool that does not require any special preparation or contrast agents, making it suitable for a wide range of patients. Hence these factors contribute to its increased preference among healthcare professionals.
   

Based on treatment, the kidney stone management market is categorized into extracorporeal shock wave lithotripsy (ESWL), ureteroscopy, percutaneous nephrolithotomy (PCNL), and other treatments. The extracorporeal shock wave lithotripsy segment dominated the market with a market share of 58.2% in 2023.
 

• ESWL is a non-invasive treatment option that uses shock waves to break kidney stones into smaller fragments that can be passed naturally through the urinary tract.
   
• Moreover, the success rate of ESWL is high, especially for stones that are composed of materials that fragment easily, such as calcium oxalate and uric acid stones. Thus, owing to such features extracorporeal shock wave lithotripsy treatment type is anticipated to contribute substantially to the market growth.
   

Based on end-use, the kidney stone management market is categorized into hospitals, specialty clinics, ambulatory surgical centers, and other end-users. The hospitals segment dominated the market with a revenue of USD 1.3 billion in 2023.

• Hospitals are equipped to manage emergencies, such as acute renal colic or severe complications from kidney stones, which often require immediate medical intervention. The presence of emergency departments ensures that patients can receive prompt and comprehensive care at any time.
   
• Moreover, hospitals typically have access to the latest medical technologies and equipment required for effective kidney stone management, including advanced medical imaging systems, laser lithotripters, and surgical robots systems. Hence the availability of aforementioned treatment modalities in the hospital settings is anticipated to contribute to the segmental growth.
   

North America kidney stone management market accounted for USD 1.1 billion revenue in 2023 and is predicted to witness substantial market growth over the analysis timeline.
 

• The prevalence of kidney stones in North America has been increasing due to dietary and lifestyle factors. Diets high in salt, protein, and oxalate-rich foods, combined with low fluid intake, contribute to higher rates of kidney stone formation cases in the region.
   
• Additionally, North America boasts advanced healthcare infrastructure, including well-equipped hospitals and specialty clinics that provide comprehensive kidney stone management services to the patients.
   

The U.S. kidney stone management market is anticipated to reach USD 1.5 billion by 2032.
 

• Favourable insurance policies in the U.S. ensure that a significant portion of the costs associated with kidney stone diagnosis and treatment is covered. This includes coverage for advanced treatments and surgical procedures.
   
• Furthermore, reimbursement policies that support kidney function tests or advanced diagnostic tests and minimally invasive treatments encourage patients to seek early and appropriate care.
   

The kidney stone management market in the UK is expected to experience significant and promising growth from 2024 to 2032.
 

• The UK has a well-developed healthcare infrastructure with advanced diagnostic and treatment facilities for kidney stone management. This includes hospitals equipped with the latest technology and specialized urology clinics.
   
• Additionally, there are ongoing public health campaigns in the UK to raise awareness about kidney stones, their symptoms, and preventive measures. Increased awareness leads to early diagnosis and timely treatment, improving patient outcomes, and increasing demand for kidney stone management.
   

Japan kidney stone management market is anticipated to witness lucrative growth between 2024 – 2032.
 

• Government initiatives aimed at improving public health and reducing the burden of kidney stones, such as funding for research, public awareness campaigns, and policies promoting healthy lifestyles support market growth.
   
• Furthermore, Japan is actively involved in clinical research and trials focused on kidney stone management. Ongoing research efforts aim to understand the pathophysiology of kidney stones, develop new treatments, and improve existing technologies.
   

Kidney Stone Management Market Share

The kidney stone management industry is consolidated in nature, with various large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel devices with improved efficiency and cost-effectiveness are key market strategies for kidney stone management key players, driving competition and innovation in the industry.
 

Kidney Stone Management Market Companies

Some of the eminent market participants operating in the kidney stone management industry include:

• Allengers Medical Systems Ltd
• Becton, Dickinson and Company
• Boston Scientific Corporation
• Coloplast A/S
• Cook Medical LLC
• DirexGroup
• Dornier MedTech
• EDAP TMS S.A
• Elmed Medical Systems
• Karl Storz GmbH
• Medispec Ltd
• Olympus Corporation
• Richard Wolf GmbH
• Siemens Healthineers
   

Kidney Stone Management Industry News:

• In April 2024, Cook Medical introduced its new Ascend single-use flexible ureteroscope in Canada and the U.S. This development is projected to improve its regional presence with expanded product range.
   
• In February 2023, Boston Scientific Corporation received FDA approval for its new digital flexible ureteroscope system, LithoVue Elite. This launch improved the company’s product offering for kidney stone management and enabled them to increase their customer base.
   

Kidney stone management market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 to 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Type

• Calcium oxalate
• Calcium phosphate
• Uric acid
• Struvite
• Cysteine

Market, By Diagnostics

• Abdominal X-ray
• Computed tomography
• Ultrasound
• Abdominal MRI
• Intravenous pyelography
• Other diagnostics

Market, By Treatment 

• Extracorporeal shock wave lithotripsy (ESWL)
• Ureteroscopy
• Percutaneous nephrolithotomy (PCNL)
• Other treatments

Market, By End-use  

• Hospitals
• Specialty clinics
• Ambulatory surgical centers
• Other end-users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East and Africa